Seroprevalence of SARS-CoV-2 and factors related in a population affiliated with a private health insurer in Bogotá, Colombia. Med Int Méx 2023; 39 (2): 243-250. https://doi.org/10.24245/mim.v39i2.7568 Mauricio Serra-Tamayo,1 Milcíades Ibañez-Pinilla,2 Víctor Alexander Saenz,1 Laura Forero,1 Jorge…
Correlation between ventilation perfusion PaO2/FiO2 ratio and SpO2/FiO2 ratio in hospitalized adult COVID-19 patients. Med Int Méx 2023; 39 (2): 227-234. https://doi.org/10.24245/mim.v39i2.7475 Idalid Itzel Mendoza-Morimoto, Rocío Milagro López-López Servicio de Medicina Interna, Hospital de…
Omicron variant and the immune scape. Med Int Méx 2023; 39 (1): 167-169. https://doi.org/10.24245/mim.v39i1.7965 Alfredo Cabrera-Rayo Internista-intensivista. Coordinador auxiliar de investigación en salud, IMSS. Resumen La incidencia de la variante ómicron del…
Multi-facetic tropism of SARS-CoV-2. Med Int Méx 2023; 39 (1): 108-113. https://doi.org/10.24245/mim.v39i1.7734 Luis Del Carpio-Orantes, Jesús Salvador Sánchez-Díaz, Sergio García-Méndez, Ada Lili Rosas-Lozano, Andrés Aguilar-Silva, Saray Guadalupe Mejía-Ramos Grupo de estudio para…
Tocilizumab, a cutting-edge therapeutic resource against SARS-CoV-2 infection: A scoping review. Med Int Méx 2023; 39 (1): 66-90. https://doi.org/10.24245/mim.v39i1.7847 Eduardo Tuta-Quintero,1 Claudia Mora-Karam,1 Julia Camacho-Osorio,1 Santiago Rhenals-Acuña,2 Francisco Arrieta-Acuña,2 Daniela Pérez-Mantilla,3 Nicolás Cristiano-Alvarado,4 Juan Pimentel1 1 Facultad de Medicina, Universidad…
Probability of hospitalization for chronic degenerative diseases in patients with COVID-19. Med Int Méx 2023; 39 (1): 39-45. https://doi.org/10.24245/mim.v39i1.7447 Enrique Villarreal-Ríos,1 María Guadalupe Ángeles-Correa,1 Liliana Galicia-Rodríguez,1 Gabriel Frontana-Vázquez,2 Emma Rosa Vargas-Daza,1 Sergio Javier Monroy-Amaro,3 Viridiana Ruiz-Pinal,3 Javier Dávalos-Álvarez,4 Shaid Santibáñez-Beltrán4…
Toxic hepatitis as manifestation of intoxication due to chlorine dioxide as prophylactic use against infection due to virus SARS-CoV-2. Med Int Méx 2022; 38 (5): 1132-1135. https://doi.org/10.24245/mim.v38i5.7045 Heriberto Martínez-Camacho,1 Lorena Morfín,2 Arabela Brito,2 Brandon Cruz2…
Extrapulmonary manifestations of COVID-19. Med Int Méx 2022; 38 (5): 1025-1040. https://doi.org/10.24245/mim.v38i5.4745 Luis Guillermo Moreno-Madrigal, Arturo Eduardo Hernández-Lima Medicina Interna, Hospital General Regional núm. 1 Dr. Carlos MacGregor Sánchez Navarro, Instituto Mexicano…
Clinic-ventilatory differences between patients with orotracheal intubation due to COVID-19 with criteria for tracheotomy compared with those without criteria. Med Int Méx 2022; 38 (4): 791-803. https://doi.org/10.24245/mim.v38i4.6940 Martha Jeanneth Jiménez-Rodríguez,1 Juan Antonio Lugo-Machado,2 Adrián…
Simultaneous systemic thrombosis as a manifestation of COVID-19. Med Int Méx 2022; 38 (4): 960-963. https://doi.org/10.24245/mim.v38i4.7399 Jesús Samuel Borges-López,1 Adán Rafael Mares-Orozco,1 José Luis Barón-Caballero,2 Eduardo Ayala-Hernández,3 Luis Manuel Borges-López4 1 Servicio de Cardiología. 2 Servicio de Ecocardiografía….